SLCO4A1 is a Prognosis-Associated Biomarker Involved in Neutrophil-Mediated Immunity in Thyroid Cancer

References

• Torre LA, Siegel RL, Ward EM, et al. Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol Biomarkers Prev. 2016;25(1):16–27. doi:10.1158/1055-9965.EPI-15-0578
   PubMed Web of Science ®Google Scholar
• Gao B, Guo L, Luo D, et al. Steroid receptor coactivator-1 interacts with NF-κB to increase the VEGFC level in human thyroid cancer. Biosci Rep. 2018;38:BSR20180394. doi:10.1042/BSR20180394
   PubMed Web of Science ®Google Scholar
• Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–2921. doi:10.1158/0008-5472.CAN-14-0155
   PubMed Web of Science ®Google Scholar
• Cooper D, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–1214. doi:10.1089/thy.2009.0110
   PubMed Web of Science ®Google Scholar
• Qi Y, Ji M, Guan H, et al. Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways. J Clin Endocrinol Metab. 2013;98(12):E1909–E1917. doi:10.1210/jc.2013-2583
   PubMed Web of Science ®Google Scholar
• Luster M, Mäder U, Giovanella L, et al. European perspective on the 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Proceedings of an interactive international symposium. Thyroid. 2018;28:722–728. doi:10.1089/thy.2017.0352
   PubMed Web of Science ®Google Scholar
• Shoup M, Stojadinovic A, Nissan A. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg. 2003;197(2):191–197. doi:10.1016/S1072-7515(03)00332-6
   PubMed Web of Science ®Google Scholar
• Mushimiyimana I, Tomas Bosch V, Niskanen H, et al.Genomic landscapes of non-coding RNAs regulating VEGFA and VEGFC expression in endothelial cells. Mol Cell Biol. 2021;41(7):MCB–00594.
   Web of Science ®Google Scholar
• Tacconi C, Correale C, Gandelli A, et al.Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion. Gastroenterology. 2015;148(7):1438–1451.
   PubMed Web of Science ®Google Scholar
• Demei M, XiangXin L, YongPing X, et al. Vascular endothelial growth factor C expression is closely correlated with lymph node recurrence and poor prognosis in patients with early stage cervical cancer. J Int Med Res. 2013;41(5):1541–1549. doi:10.1177/0300060513493038
   PubMed Web of Science ®Google Scholar
• Razy N, Wan F, Win TT. Expression of vascular endothelial growth factor and its receptors in thyroid nodular hyperplasia and papillary thyroid carcinoma: a tertiary health care centre based study. APJCP. 2019;20(1):277.
   Google Scholar
• Yu X-M, Lo C-Y, Chan W-F, Lam K-Y, Leung P, Luk JM. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases. Clin Cancer Res. 2005;11(22):8063–8069. doi:10.1158/1078-0432.CCR-05-0646
   PubMed Web of Science ®Google Scholar
• Stieger B, Hagenbuch B. Organic anion-transporting polypeptides. Curr Top Membr. 2014;73(73):205–232.
   PubMed Web of Science ®Google Scholar
• Buxhofer-Ausch V, Secky L, Wlcek K, et al. Tumor-specific expression of organic anion-transporting polypeptides: transporters as novel targets for cancer therapy. J Drug Deliv. 2013;2013:863539. doi:10.1155/2013/863539
   PubMedGoogle Scholar
• Brenner S, Klameth L, Riha J, et al. Specific expression of OATPs in primary small cell lung cancer (SCLC) cells as novel biomarkers for diagnosis and therapy. Cancer Lett. 2014;356(2):517–524.
   PubMed Web of Science ®Google Scholar
• Kleberg K, Jensen GM, Christensen DP. Transporter function and cyclic AMP turnover in normal colonic mucosa from patients with and without colorectal neoplasia. BMC Gastroenterol. 2012;12(1):78. doi:10.1186/1471-230X-12-78
   PubMed Web of Science ®Google Scholar
• Hays A, Apte U, Hagenbuch B. Organic anion transporting polypeptides expressed in pancreatic cancer may serve as potential diagnostic markers and therapeutic targets for early stage adenocarcinomas. Pharm Res. 2013;30(9):2260. doi:10.1007/s11095-012-0962-7
   PubMed Web of Science ®Google Scholar
• Lanczky A, Gyorffy B. Web-based survival analysis tool tailored for medical research (KMplot): development and implementation. J Med Internet Res. 2021;23(7):e27633. doi:10.2196/27633
   PubMed Web of Science ®Google Scholar
• Wright JL, Kwon EM, Ostrander EA, et al. Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes. Cancer Epidemiol Biomark Prev. 2011;20(4):619. doi:10.1158/1055-9965.EPI-10-1023
   PubMed Web of Science ®Google Scholar
• Gu Y, Hu C. Bioinformatic analysis of the prognostic value and potential regulatory network of FOXF1 in papillary thyroid cancer. Biofactors. 2019;45(6):902–911. doi:10.1002/biof.1561
   PubMed Web of Science ®Google Scholar
• Moeller LC, Fuhrer D. Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective. Endocr Relat Cancer. 2013;20(2):R19–R29. doi:10.1530/ERC-12-0219
   PubMed Web of Science ®Google Scholar
• He LZ, Zeng T-S, Pu L, et al. Thyroid hormones, autoantibodies, ultrasonography, and clinical parameters for predicting thyroid cancer. Int J Endocrinol. 2016;2016:1–11. doi:10.1155/2016/8215834
   Web of Science ®Google Scholar
• Granot Z. Neutrophils as a therapeutic target in cancer. Front Immunol. 2019;10:1710. doi:10.3389/fimmu.2019.01710
   PubMed Web of Science ®Google Scholar